Handelsbanken Fonder’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,788
| Closed | -$273K | – | 1549 |
|
|
2025
Q1 | $273K | Hold |
30,788
| – | – | ﹤0.01% | 1433 |
|
|
2024
Q4 | $422K | Buy |
30,788
+3,500
| +13% | +$48K | ﹤0.01% | 1353 |
|
|
2024
Q3 | $747K | Buy |
27,288
+3,100
| +13% | +$84.9K | ﹤0.01% | 1066 |
|
|
2024
Q2 | $592K | Buy |
24,188
+2,000
| +9% | +$49K | ﹤0.01% | 1076 |
|
|
2024
Q1 | $473K | Buy |
22,188
+4,900
| +28% | +$104K | ﹤0.01% | 1189 |
|
|
2023
Q4 | $331K | Buy |
17,288
+2,800
| +19% | +$53.6K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $232K | Hold |
14,488
| – | – | ﹤0.01% | 1404 |
|
|
2023
Q2 | $336K | Hold |
14,488
| – | – | ﹤0.01% | 1288 |
|
|
2023
Q1 | $337K | Hold |
14,488
| – | – | ﹤0.01% | 1224 |
|
|
2022
Q4 | $210K | Hold |
14,488
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q3 | $276K | Hold |
14,488
| – | – | ﹤0.01% | 1291 |
|
|
2022
Q2 | $263K | Hold |
14,488
| – | – | ﹤0.01% | 1400 |
|
|
2022
Q1 | $365K | Sell |
14,488
-3,600
| -20% | -$90.7K | ﹤0.01% | 1405 |
|
|
2021
Q4 | $499K | Sell |
18,088
-800
| -4% | -$22.1K | ﹤0.01% | 1341 |
|
|
2021
Q3 | $610K | Hold |
18,888
| – | – | ﹤0.01% | 1219 |
|
|
2021
Q2 | $578K | Buy |
18,888
+6,900
| +58% | +$211K | ﹤0.01% | 1273 |
|
|
2021
Q1 | $365K | Hold |
11,988
| – | – | ﹤0.01% | 1360 |
|
|
2020
Q4 | $237K | Hold |
11,988
| – | – | ﹤0.01% | 1480 |
|
|
2020
Q3 | $156K | Hold |
11,988
| – | – | ﹤0.01% | 1421 |
|
|
2020
Q2 | $136K | Buy |
+11,988
| New | +$136K | ﹤0.01% | 1416 |
|